Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
58-61-7
|
| gptkbp:component |
gptkb:ATP
gptkb:cAMP gptkb:gene gptkb:ADP gptkb:FAD NAD+ |
| gptkbp:form |
C10H13N5O4
|
| gptkbp:foundIn |
animals
plants human body |
| gptkbp:hasBiologicalActivity |
sleep regulation
modulation of immune response regulation of blood flow inhibition of neurotransmitter release anti-inflammatory effect regulation of myocardial oxygen consumption |
| gptkbp:hasInChIKey |
OIRDTQYFTABQOQ-KQYNXXCUSA-N
|
| gptkbp:hasRole |
immunotherapy
neurotransmitter vasodilator |
| gptkbp:hasSMILES |
C1=NC2=C(N1)N=CN2C3C(C(C(O3)CO)O)O
|
| https://www.w3.org/2000/01/rdf-schema#label |
C00242
|
| gptkbp:involvedIn |
signal transduction
cell signaling energy transfer vasodilation purine metabolism cardiac function regulation nucleic acid synthesis sleep-wake cycle regulation |
| gptkbp:isDegradedBy |
gptkb:adenosine_deaminase
|
| gptkbp:IUPACName |
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
|
| gptkbp:KEGGID |
gptkb:C00242
|
| gptkbp:molecularWeight |
267.24 g/mol
|
| gptkbp:name |
gptkb:Adenosine
|
| gptkbp:predecessor |
gptkb:adenosine_triphosphate
gptkb:cyclic_adenosine_monophosphate gptkb:adenosine_diphosphate adenosine monophosphate |
| gptkbp:producedBy |
gptkb:adenosine_kinase
|
| gptkbp:PubChem_CID |
16335
60961 |
| gptkbp:target |
gptkb:adenosine_receptors
|
| gptkbp:usedFor |
pharmaceutical agent
|
| gptkbp:bfsParent |
gptkb:Guanine
|
| gptkbp:bfsLayer |
6
|